MTC is an aggressive neuroendocrine tumor that releases the neurotransmitter calcitonin gene-related peptide (CGRP) and develops from thyroid parafollicular cells, usually with a poor prognosis [167]. This evidence concerns the gene CALCA and medullary thyroid gland carcinoma.